| mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.9 |
| mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |